Kisunla Injection 350MG/20ML Vial

Kisunla (donanemab) is a monoclonal antibody medicine indicated for the treatment of Alzheimer’s disease. It works by targeting amyloid-beta plaques in the brain, which are associated with Alzheimer’s disease.

The medicine is supplied as a 350 mg / 20 mL single-dose vial and is administered by a healthcare professional as an intravenous (IV) infusion.